Chan Beals MD PhD
Chief Medical Officer, Abide Therapeutics, San Diego CA
Join to View Full Profile
Solana CircleSolana Beach, CA 92075
Phone+1 908-839-3395
Dr. Beals is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Rheumatology, 1992 - 1995- University of California (San Francisco)Residency, Pediatrics, 1990 - 1992
University of Washington School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - Present
CT State Medical License 2002 - 2023
Clinical Trials
- A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome Start of enrollment: 2017 Feb 01
- Titration Study of ABX-1431 Start of enrollment: 2017 Oct 02
- Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder Start of enrollment: 2018 Oct 15
Publications & Presentations
PubMed
- 2 citationsPatient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD).Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Nuran Dilek
Orphanet Journal of Rare Diseases. 2024-03-19 - 37 citationsNative Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes.Sudha S. Shankar, R. Ravi Shankar, Lori A. Mixson, Deborah L. Miller, Barnali Pramanik
Diabetes. 2018-06-01 - 1 citationsInsulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challengeSudha S. Shankar, R. Ravi Shankar, Lori A. Mixson, Deborah L. Miller, Helmut O. Steinberg
American Journal of Physiology. Endocrinology and Metabolism. 2018-04-01
Press Mentions
- A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
- Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
- Autobahn Therapeutics Strengthens Management Team to Support Advancement of Novel Therapies for CNS DisordersSeptember 14th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
